Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03113539
Other study ID # 2016-1074
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 12, 2017
Est. completion date May 30, 2019

Study information

Verified date July 2019
Source Université de Sherbrooke
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

We will demonstrate the validity of measurements with a low-dose, EKG-gated CT without contrast in the ascending aorta evaluation, compared with the current Angio-CT measurements.


Description:

The actual protocol used in aorta evaluation consist of two CT-scans on the same study. The first scan that detects calcifications is using parameters with low-dose current, non EKG-gated and without contrast. The second scan uses iodine-contrast, EKG-gating and higher current dose to obtain higher image quality of diagnostic value.

The study will optimize the first scan parameters and compare the measures of the aorta diameters from the standard protocol.

By modifying the first scan parameters, we would demonstrate that the follow-up of an aortic aneurysm can safely be made with lower radiation exposure.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date May 30, 2019
Est. primary completion date April 30, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years to 100 Years
Eligibility Inclusion Criteria:

- 60 years old and more

- 85 bpm or less

Exclusion Criteria:

- aortic material

- EKG gating not possible

- aorta pathology (thrombus, dissection)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Modified Low-dose, EKG-gated CT without contrast for the evaluation of aortic aneurysm
On the same day, the subject will do : Modified low-dose, EKG-gated CT without contrast Usual high-dose, EKG-gated CT with contrast Comparing aortic diameters from the two protocols.

Locations

Country Name City State
Canada Sherbrooke University Hospital Sherbrooke Quebec

Sponsors (1)

Lead Sponsor Collaborator
Université de Sherbrooke

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measures validity (aorta diameter in mm from scan images) Comparing aorta diameters from the two modalities. 12 months
Secondary Radiation (in msev from scanner report) Comparing radiation exposure with the two modalities 12 months